Last updated on January 2019

Study of the Efficacy and Safety of DigiFab in Antepartum Subjects With Severe Preeclampsia

Brief description of study

This study evaluates the use of Digoxin immune fab in addition to expectant management in the treatment of severe preeclampsia as compared to placebo.

Clinical Study Identifier: NCT03008616

Contact Investigators or Research Sites near you

Start Over

Casey Armistead, RN

University of South Alabama
Mobile, AL United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.